SNT 2.22% 4.4¢ syntara limited

Ann: After FDA Review PXS Accelerates Plans for Combination Study, page-2

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 7,135 Posts.
    lightbulb Created with Sketch. 546
    The mid-term PXS-5505 should be out within days!
    The result from initial 6 patients was good, let's see...
 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.